Chiesi Global Rare Diseases Announces FDA Approval of FERRIPROX® (deferiprone) for …,

A controlled study that compared the efficacy of FERRIPROX to that of … The most common adverse reactions reported during clinical trials in patients …, A controlled study that compared the efficacy of FERRIPROX to that of … The most common adverse reactions reported during clinical trials in patients …, Read More

Scroll to Top